My watch list  

Overactive Bladder

News Overactive Bladder

  • Study shows mirabegron effective and well tolerated for overactive bladder

    In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with overactive bladder (OAB) compared to those in a placebo group. The incidence more

  • Provesica Starts Phase 2 Study in Overactive Bladder

    Provesica Ltd, a clinical-stage company developing a novel therapeutic approach to overactive bladder, announced that it had initiated a Phase 2 study of overactive bladder with its lead product XEN-D0501. XEN-D0501 is an antagonist of the TRPV1 receptor which is expressed both in the bladder and on more

  • BioXell announces restructuring following review of portfolio

    BioXell S.p.A. announced the initiation of a redundancy procedure (Procedura di Mobilità according to Sec. 4 and 24 of Italian Law 223/1991) in order to align its internal organization and resources as a result of BioXell's reduced product pipeline and the relating research & development activities. more

All news on overactive bladder

Publications Overactive Bladder

All publications on overactive bladder

Overactive bladder

Overactive bladder Overactive bladder (OAB) is a urological condition defined by a set of symptoms: "urgency, with or without urge incontinence , usually with frequency and nocturia ." The International Continence Society (ICS) is responsi ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE